Microbiota and Carcinogenesis of Small-intestine Neuroendocrine Tumors
Recruiting
Observational Study
Small-intestine Neuroendocrine Tumors
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 75 (estimated)
- Sponsor
- Hospices Civils de Lyon · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The aim of the study is to investigate the impact of the microenvironment on tumorigenesis of small intestinal neuroendocrine tumors often located in the terminal ileum, without identified driver mutations.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patient with one or more small-intestine neuroendocrine tumor with indication of surgery
* Patient with consent for the collection, storage and reuse of data associated with his/her disease
* Age ≥ 18 years at the time of inclusion
* Non-objection statement obtained for partic…
Contacts